OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Promising effects of atorvastatin on mortality and need for mechanical ventilation in patients with severe COVID‐19; a retrospective cohort study
Mohammad Haji Aghajani, Omid Moradi, Hamed Azhdari Tehrani, et al.
International Journal of Clinical Practice (2021) Vol. 75, Iss. 9
Open Access | Times Cited: 12

Showing 12 citing articles:

A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin
Luis Adrián De Jesús‐González, Rosa M. del Ángel, Selvin Noé Palacios-Rápalo, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 383-383
Open Access | Times Cited: 5

Association of Statins for Primary Prevention of Cardiovascular Diseases With Hospitalization for COVID‐19: A Nationwide Matched Population‐Based Cohort Study
Kim Bouillon, Bérangère Baricault, Laura Semenzato, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 12
Open Access | Times Cited: 19

Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 Patients
Ut-Sam Lao, Chak-Fun Law, Daniel T. Baptista‐Hon, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5454-5454
Open Access | Times Cited: 19

Atorvastatin for reduction of 28-day mortality in severe and critical COVID-19 patients: a randomized controlled trial
Naglaa Hamdi Eltahan, Neamat Hamdy Elsawy, Kholoud M. Abdelaaty, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 3

Atorvastatin for Reduction of 28-day Mortality in Sever and Critical COVID-19 Patients: A Randomized Controlled Trial
Naglaa Hamdi Eltahan, Neamat Hamdy Elsawy, Kholoud M. Abdelaaty, et al.
Research Square (Research Square) (2023)
Closed Access

Statins: Beneficial Effects in Treatment of COVID-19
Naser‐Aldin Lashgari, Nazanin Momeni Roudsari, Hedieh Sadat Shamsnia, et al.
Advances in experimental medicine and biology (2023), pp. 457-476
Closed Access

Atorvastatin: old friend in the light of novel coronavirus infection’s pandemia
М. В. Ежов, Т. Е. Колмакова, М. А. Матвеева, et al.
Meditsinskiy sovet = Medical Council (2022), Iss. 4, pp. 82-88
Open Access

Effects of Statins on Clinical Outcomes in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Paulo Ricardo Martins‐Filho, José Augusto Soares Barreto-Filho, Antônio Carlos Sobral Sousa
SSRN Electronic Journal (2022)
Closed Access

Phenotypical and Functional Alteration of γδ T Lymphocytes in COVID-19 Patients: Reversal by Statins
Marta Di Simone, Anna Maria Corsale, Elena Lo Presti, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3449-3449
Open Access

Page 1

Scroll to top